Li, Y., Wang, G., Griffin, L., Banda, N. K., Saba, L. M., Groman, E. V., . . . Simberg, D. (2021). Complement opsonization of nanoparticles: Differences between humans and preclinical species. Journal of controlled release, 338, 548-556. https://doi.org/10.1016/j.jconrel.2021.08.048
Chicago Style (17th ed.) CitationLi, Yue, Guankui Wang, Lynn Griffin, Nirmal K. Banda, Laura M. Saba, Ernest V. Groman, Robert Scheinman, S. Moein Moghimi, and Dmitri Simberg. "Complement Opsonization of Nanoparticles: Differences Between Humans and Preclinical Species." Journal of Controlled Release 338 (2021): 548-556. https://doi.org/10.1016/j.jconrel.2021.08.048.
MLA (9th ed.) CitationLi, Yue, et al. "Complement Opsonization of Nanoparticles: Differences Between Humans and Preclinical Species." Journal of Controlled Release, vol. 338, 2021, pp. 548-556, https://doi.org/10.1016/j.jconrel.2021.08.048.